Roche announced the acquisition of Medingo Ltd., a company engaged in the development of a semi-disposable insulin patch pump.
The new Medingo Ltd. micro pump insulin delivery system consists of two parts: a semi-disposable insulin dispensing patch and a remote control, which allows for discreet personalized insulin delivery. It provides the functions of a conventional insulin pump alongside with all advantages of the innovative tubeless patch pump.
The Medingo Ltd. patch pump is not yet marketed. In a next step, production capacities will be scaled-up to prepare for global launch which is expected by 2012.
The acquisition will strengthen Roche Diabetes Care’s position in the fast growing segment of insulin delivery systems.
